Gowling WLG advised Innocan on this transaction.Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has successfully completed the second and final tranche of its previously…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
